Today’s podcast will cover drug testing for stimulants and will highlight some of the challenges in results interpretation for this class of drugs. Important information shared during the discussion will include:
- What is classified as a stimulant
- Analysis of Amphetamine, Methamphetamine, and MDMA
- Interpretation challenges
- Synthetic stimulants
- The role of clinical drug monitoring
- Quest Diagnostics amphetamine drug testing offering
The episode features Dr Les Edinboro, PhD, executive science director, and Dr Jeff Gudin, senior medical advisor, Quest Diagnostics Drug Monitoring and Toxicology.
To listen to other podcasts in our “Topics in Drug Testing” series, or learn more about Quest Diagnostics comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insight to support your clinical decisions.